BMAL1 and nasopharyngeal carcinoma: The upregulation of Bmal1 was found to inhibit cell proliferation, increase the sensitivity of NPC cells to radiotherapy, and increase the expression of p53 and p21, whereas the knockdown of Bmal11 had the opposite effect [66].